Modified percutaneous nephropexy for nephroptosis: Technical description and short-term results
- PMID: 40376470
- PMCID: PMC12076343
- DOI: 10.1097/CU9.0000000000000238
Modified percutaneous nephropexy for nephroptosis: Technical description and short-term results
Abstract
Objectives: Percutaneous nephropexy (PCN) has been demonstrated as a feasible method for treating nephroptosis. This study describes an improved technique for PCN that better addresses the issue of nephroptosis.
Materials and methods: We reviewed 4 patients who underwent the improved PCN procedure between January 2021 and January 2023. These patients were diagnosed with nephroptosis, with 1 case having both a narrow ureteropelvic junction and nephroptosis due to a kidney stone, and 3 cases having simple nephroptosis. Patient characteristics, perioperative data, and follow-up results were collected. Surgical success was determined by symptom relief (subjective success) and the absence of kidney descent by intravenous pyelography (objective success).
Results: Preoperative computed tomography urography showed that all patients had hydronephrosis, with severe hydronephrosis in 75% (3/4) and moderate hydronephrosis in 25% (1/4) of cases. The mean operative time was 63.8 minutes (range, 45-95 minutes), and the mean blood loss was 5 mL (range, 5-50 mL). The mean length of hospital stay was 4.5 days (range, 3-6 days). The mean time to removal of the nephrostomy tube was 2 months (range, 1-4 months). No serious complications (Clavien-Dindo grade ≥3) occurred during or after the procedure. The mean postoperative serum creatinine level was 54.75 μmol/L (range, 43-65 μmol/L). The mean follow-up time was 6.25 months (range, 4-8 months). The objective and subjective success rates were both 100%.
Conclusions: The improved PCN procedure that was used in this study is feasible and provides a good option for treating nephroptosis.
Keywords: Hydronephrosis; Intravenous pyelography; Nephropexy; Nephroptosis.
Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
XL is an associate editor of Current Urology. This article was accepted after a normal external review. No conflict of interest has been declared by the other authors.
Figures


Similar articles
-
Retroperitoneoscopic pyeloplasty with concomitant neophropexy for a ureteropelvic junction obstruction in combination with nephroptosis.Aktuelle Urol. 2010 Jan;41 Suppl 1:S27-9. doi: 10.1055/s-0029-1224659. Epub 2010 Jan 21. Aktuelle Urol. 2010. PMID: 20094948
-
Retroperitoneoscopic nephropexy for symptomatic nephroptosis.Surg Endosc. 2002 Nov;16(11):1603-7. doi: 10.1007/s00464-001-8224-5. Epub 2002 May 3. Surg Endosc. 2002. PMID: 11984663
-
Percutaneous endoscopic nephropexy with a percutaneous suture passed through the kidney.Arab J Urol. 2013 Mar;11(1):68-73. doi: 10.1016/j.aju.2013.01.002. Epub 2013 Feb 4. Arab J Urol. 2013. PMID: 26579248 Free PMC article.
-
Retroperitoneoscopic nephropexy for symptomatic nephroptosis using a modified three-point fixation technique.Urology. 2005 Sep;66(3):644-8. doi: 10.1016/j.urology.2005.03.046. Urology. 2005. PMID: 16140095
-
Clinical reappraisal and state of the art of nephropexy.Urologia. 2018 Nov;85(4):135-144. doi: 10.1177/0391560317749191. Epub 2018 Apr 11. Urologia. 2018. PMID: 29637838 Review.
References
-
- Fornara P, Doehn C, Jocham D. Laparoscopic nephropexy: 3-year experience. J Urol 1997;158(5):1679–1683. - PubMed
-
- Wang K, Fan M, Shao F, Hu F, Xia X. Nephroptosis incidentally found on 99 m Tc-DTPA renal dynamic scan. Clin Nucl Med 2022;47(12):1099–1100. - PubMed
-
- Yoshida S Matsumura M Maekawa K, et al. . Recurrent abdominal pain caused by nephroptosis. Clin J Gastroenterol 2020;13(4):621–625. - PubMed
-
- Plas E, Daha K, Riedl CR, Hübner WA, Pflüger H. Long-term followup after laparoscopic nephropexy for symptomatic nephroptosis. J Urol 2001;166(2):449–452. - PubMed
LinkOut - more resources
Full Text Sources